Polynovo (OTC:CALZF) Stock, Quote.Headers.trade-ideas

Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

News

Intraday Update

Markets

Movers

Trading Ideas

ACAZF

ACRE

ADBE

ADSK

AJRD

AKAAF

AKBA

AMRC

AMSF

AMWD

APPF

APTO

ARDX

ASHTY

ATGFF

AZRE

BABYF

BOWFF

BROG

BRUZF

BURL

BWXT

BYCBF

CALX

CALZF

CCLAF

CCLAY

CDUAF

CELTF

CGEN

CHCT

CLGX

CLHRF

CNCN

COUP

CRMT

CVNA

CWEN

CWEN-A

CWST

CYBE

DOOR

DTRC

DUVNF

DYFSF

EHTH

ELRRF

ENBP

EPAM

ETFC

EVER

EVRI

EXPO

FARO

FAST

FATE

Stocks That Hit 52-Week Highs On Thursday

Polynovo Ltd

Polynovo

Comments

Polynovo

Polynovo (OTC:CALZF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga